The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation
Authors
Keywords
-
Journal
JOURNAL OF PSYCHOPHARMACOLOGY
Volume 36, Issue 1, Pages 114-125
Publisher
SAGE Publications
Online
2022-01-04
DOI
10.1177/02698811211064720
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research
- (2021) Sara J. Tai et al. Frontiers in Psychiatry
- An episode of mania following self‐reported ingestion of psilocybin mushrooms in a woman previously not diagnosed with bipolar disorder: A case report
- (2021) Holly M. Hendin et al. BIPOLAR DISORDERS
- New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review
- (2021) Fabrizio Schifano et al. EXPERIMENTAL NEUROLOGY
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
- (2019) Martin K. Madsen et al. NEUROPSYCHOPHARMACOLOGY
- Social cognitive dysfunction as a clinical marker: A systematic review of meta-analyses across 30 clinical conditions
- (2018) Jack Cotter et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Psilocybin and MDMA reduce costly punishment in the Ultimatum Game
- (2018) Anthony S. Gabay et al. Scientific Reports
- Social Cognition through the Lens of Cognitive and Clinical Neuroscience
- (2018) Maria Arioli et al. Biomed Research International
- Effect of Psilocybin on Empathy and Moral Decision-Making
- (2017) Thomas Pokorny et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
- (2017) Robin L Carhart-Harris et al. NEUROPSYCHOPHARMACOLOGY
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
- (2017) R. L. Carhart-Harris et al. PSYCHOPHARMACOLOGY
- Psychedelics in the treatment of unipolar mood disorders: a systematic review
- (2016) James JH Rucker et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effects of serotonin 2A/1A receptor stimulation on social exclusion processing
- (2016) Katrin H. Preller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Early Social-Emotional Functioning and Public Health: The Relationship Between Kindergarten Social Competence and Future Wellness
- (2015) Damon E. Jones et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers
- (2015) Rainer Kraehenmann et al. BIOLOGICAL PSYCHIATRY
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
- (2015) Michael P Bogenschutz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases
- (2014) Ruud P.W. Litjens et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
- (2014) Matthew W Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Spatiotemporal Brain Dynamics of Emotional Face Processing Modulations Induced by the Serotonin 1A/2A Receptor Agonist Psilocybin
- (2013) F. Bernasconi et al. CEREBRAL CORTEX
- Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors
- (2012) Michael Kometer et al. BIOLOGICAL PSYCHIATRY
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
- (2012) R. L. Carhart-Harris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
- (2011) Adam L. Halberstadt et al. NEUROPHARMACOLOGY
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
- (2011) Roland R. Griffiths et al. PSYCHOPHARMACOLOGY
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
- (2010) Charles S. Grob et al. ARCHIVES OF GENERAL PSYCHIATRY
- Serotonin selectively influences moral judgment and behavior through effects on harm aversion
- (2010) M. J. Crockett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
- (2008) RR Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started